Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
Peyronie's disease (PD) is a fibrotic disorder of the tunica albuginea of the penis. It is characterized by different degrees of penile curvature and sexual dysfunction. Several medical treatments have been employed to manage the disorder, with variable success rates. Surgical therapy is reserv...
Saved in:
Main Authors: | Tariq F. Al-Shaiji, Gerald B. Brock |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2009.101 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peyronie’s Disease: Still a Surgical Disease
by: Daniel Martinez, et al.
Published: (2012-01-01) -
Biomechanical Simulation of Peyronie’s Disease
by: Pavel Drlík, et al.
Published: (2021-01-01) -
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
by: Christina Alves Peixoto, et al.
Published: (2015-01-01) -
Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01) -
Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats
by: Fred Kim, et al.
Published: (2025-01-01)